• Blog
  • Molecular Chlamydia Trachomatis Neisseria Gonorrhoeae Diagnostic Equipment Market Report

    Molecular Chlamydia Trachomatis Neisseria Gonorrhoeae Diagnostic Equipment Market Report

    Molecular Chlamydia Trachomatis Neisseria Gonorrhoeae Diagnostic Equipment Market Report
    Report code - SR1447 Delivery - 2 Weeks
    Get Free Sample |
    Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Marke See more...

    Impact of COVID-19 on Molecular Chlamydia Trachomatis Neisseria Gonorrhoeae Diagnostic Equipment Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Molecular Chlamydia Trachomatis Neisseria Gonorrhoeae Diagnostic Equipment Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of around x% during the forecast period.

    Figure: Molecular CT/NG Diagnostic Equipment Market Size, 2020-2026 (USD Billion)

    Molecular-Chlamydia-Trachomatis-(CT)/Neisseria-Gonorrhoeae-(NG)-Diagnostic-Equipment-Market-Forecast

    Wish to get a free sample? Register Here

    What are Chlamydia trachomatis and Neisseria gonorrhoeae?

    Chlamydia trachomatis and Neisseria gonorrhoeae are known to be the most prevalent sexually transmitted pathogens having high rates of infection among female commercial sex workers in developing countries. The equipment used to diagnose chlamydia trachomatis and neisseria gonorrhoeae include PCR, in situ hybridization, chips and microarrays, isothermal nucleic acid amplification technology (inaat), and mass spectrometry among others.

    Key Players

    Key players operating in the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market are-

    • Cepheid (US)
    • Becton, Dickinson and Company (US)
    • Gen-Probe (US)
    • QIAGEN (Germany)
    • F. Hoffmann-La Roche AG (Switzerland)
    • Bayer AG (Germany)
    • Dako (Denmark)
    • Abbott Laboratories (US)
    • Danaher Corporation (US)
    • Siemens AG (Germany)
    • Sysmex Corporation (Japan)
    • Grifols, S.A. (Spain)
    • bioMérieux SA (France).

    Market Dynamics

    The growth of molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment market is primarily driven by increasing incidences of sexually transmitted diseases. Growing emphasis on education campaigns to create awareness and government initiatives are anticipated to drive the growth of molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment at a significant rate during the review period. In addition to this, surging demand for advanced CT/NG diagnostic equipment is likely to create lucrative opportunities for the players operating in the global market in the coming years.

    Segments' Analysis

    Application Trends

    By application, the molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment market has been bifurcated into hospital, research and clinic. Under these, the hospitals segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.

    Regional Trends

    By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to high demand for advanced CT/NG diagnostic equipment coupled with presence of key market players such as Cepheid (US) and Becton, Dickinson and Company (US). The market growth in Asia-Pacific region is expected to be driven by rising number of people suffering from CT/NG.

    COVID-19 Impact on Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market

    The outbreak of COVID-19 virus posed significant challenges to the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product demand and supply for a short period of time.

    Critical Questions Answered in the Report

    • What are the key trends in the global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market?
    • What are the key strategies adopted by the major vendors to lead in the global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment market hopes to have the greatest opportunity to convert-

    • Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment distributors
    • Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment suppliers
    • Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Cepheid (US), Becton, Dickinson and Company (US), Gen-Probe (US), QIAGEN (Germany), F. Hoffmann-La Roche AG (Switzerland), Bayer AG (Germany), Dako (Denmark), Abbott Laborato-ries (US), Danaher Corporation (US), Siemens AG (Germany), Sysmex Corporation (Japan), Grifols, S.A. (Spain) and bioMrieux SA (France) are among the key players in the molecular CT/NG diagnostic equipment market.

    Increasing incidences of sexually transmitted diseases is the prime factor driving the growth of molecular CT/NG diagnostic equipment market.

    The hospitals segment is expected to register the significant growth in the molecular CT/NG diagnostic equipment market in the coming years.

    North America accounted for the largest share in the molecular CT/NG diagnostic equipment market in 2020.

    Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment distributors, Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment suppliers, Molecular chlamydia trachomatis (CT)/neisseria gonorrhoeae (NG) diagnostic equipment manufacturers, Logistics organizations, Government bodies are the target audience in the molecular CT/NG diagnostic equipment market.

    //